chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: 64 yo male with a history of congestive heart failure, hypercholesterolemia, colostomy, obesity, gout, hyperplastic polyp of intestine, GERD, T2DM, diverticulitis, sleep apnea, HTN, substance abuse, and cocaine dependence. Patient received covid vaccinations on 4/1/21 and 5/3/21. Not much is known about patients death other then he died at home on 7/2/21 and was found by daughter. Death is unlikely to be related to covid vaccinations.
Patient began to fill lightheaded with ringing in ears and narrowing vision approximately 15 minutes post vaccination.  On exam patient was A&OX4 Vital signs of BP 102/68, R 14, P 68, SPO2 95,  Patient placed in recumbent position and provided with apple juice.
Chest pain, blurred vision, numbness in arms and feet, persistent headache, pain in extremities, generalized aching.
ADVERSE EVENT: DARK URINE, LIMB MYALGIA, WEAKNESS, DIFFICULTY WALKING AND SITTING UPRIGHT CURRENT TREATMENT: SODIUM BICARBONATE (), METHOCARBOMAL (750 MG), IBUPROFEN (800 MG) RECOMMENDED SELF-CARE: SOAKING BATHS, SELF-MASSAGE, LIMITED MOVEMENT/WALKING, CONTINUOUS SUSTENANCE VIA ALKALINE WATER AND DIET OUTCOME: STILL SEEKING TESTING PER DR. (NEUROLOGY) - ANTICIPATING LABS/MRI BY END OF FIRST WEEK IN MAY
Within 2.5 hours of these two high dosage injections, which were given too close to each other in left arm (One small round bandaide covered them), patient started experiencing severe joint pains, weakness, nausea, and body aches.  These continued for 3 days. We alternated Ibuprofen & acetaminophen to try to get him comfortable. Two days after the injections he developed a large red swollen whelp on his upper left arm. We alternated cold & hot packs to try to get whelp to reduce. Finally added benadryl two nights and whelp has started reducing. On dat 5 since injections he has  back pain from these adverse reactions that has not resolved yet. This has affected him badly for 4 days and is going on still. The joints and other body aches have diminished greatly now. He has never had adverse reactions to prior flu or pneumonia vaccines. He should not have had two high dosage injections in the same arm nor so terribly close in proximity to each other!
A non-serious spontaneous report of patient was given expired FLUMIST was received from a health professional concerning a six-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 23-Feb-2011. On 25-Feb-2011, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information was received on 19-May-2011: Reporter confirmed that there was no late occurrence of adverse events and the patient decided not to revaccinate.
Narrative:  COVID infection following COVID vaccine series 01/21, Moderna , dose #1 02/19, Moderna , dose #2 08/17 COVID swab, result: not detected 10/04 COVID swab, result: detected 10/04 pt cc: cough exposure: unknown 10/04 SARS-COV-2 Variant Sequencing result: pending
Rash, itching, red, swollen arm a week after vaccine was given. Lasted 6 days
Patient was mistakenly given 3rd dose of moderna covid-19 vaccine bedside at long term care facility (28 days following second dose). No adverse reaction was reported by patient.
Patient reported developing spotty rash on body and some itchiness on her nipples, no other symptoms reported. Advise her to get doctor recommendations on whether second dose is beneficial to the patient
muscle soreness; redness near the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYALGIA (non-serious), outcome "unknown", described as "muscle soreness"; INJECTION SITE ERYTHEMA (non-serious), outcome "unknown", described as "redness near the injection site".  Additional information: It was reported that patient experienced muscle soreness and redness near the injection site and would like to know if it is normal.   The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
Chills; Shingles; Arm pain; Headache; fatigue; This is a spontaneous report from a contactable consumer. This 56-year-old female consumer (patient) reported that she received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot ER8727; expiry date 31Jul2021) single dose at left upper arm muscle on 28Mar2021 14:00 or 15:00 for COVID-19 immunization. Medical history included Shingles. Concomitant drugs were not provided. The patient got shingles on 05Apr2021. She got shingles blisters and the swelling was mostly gone, just about cleared. It was not completely gone she still has a few spots left from the shingles. The event required physician office visit as she wanted her doctor to look at the Shingles before she got the second vaccine. The doctor said she could get the second vaccine. She had shingles in the past. Her doctor did not feel that it was related to vaccine, but she wanted to report her symptoms. She took valacyclovir HCL (generic for Valtrex) for shingles. One gram tablet by mouth twice a day.  There were 20 tablets total.  She has arm pain and headaches on 28Mar2021, fatigue in Mar2021 and some chills on unknown date. She experienced arm pain after the first vaccine, which lasted for about 3 days. The pain decreased each day, but is unsure when it went away. She also started to feel fatigue within that week of the first vaccine, and subsided that same week. She had chills the week of the first vaccine, and went away that week. She had a headache the same day of the first vaccine and persisted that week. She did not treat her other symptoms, just drank water. Outcome of shingles was resolving, arm pain was resolved on 31Mar2021, fatigue and chills was resolved in 2021, headache was resolved on 20Apr2021.  No follow-up attempts are needed. No further information is expected.
A non-serious spontaneous report of administration to 21.5 weeks pregnant female was received from a registered nurse/health professional concerning a 19-year-old female. The patient's past medical history included non-specific uterine bleeding and concurrent conditions were peri-rectal abscess, depression and alcohol use. On 09-Sep-2009 patient stopped use of alcohol when she learned she was pregnant. Patient had regular prenatal care, labs and fetal heart tones were normal. The patient's obstetrical history included gravida three, para one and two spontaneous abortions. Patient's estimated date of delivery was 19-Mar-2010. The concomitant medications included Iron tabs, multivitamins, omega 3-fatty acid (all orally, once daily) and calcium (oral, twice daily) as supplement, acetaminophen as needed orally. The previous vaccination was 1 dose of 'TB vaccine' subcutaneously on 09-Sep-2009 and 1 dose of 'Hepatitis B vaccine' IM on 23-Sep-2009. On 12-Nov-2009, the patient received H1N1, Intranasal, for an unknown indication. On 25-Mar-2010, patient was sent to hospital in labour to deliver the infant. The patient delivered a female child on 30-Mar-2010. It was a full term normal induced vaginal delivery with no medical complications. The gestational age was 41 weeks four days. The newborn had a weight of 8 lbs 12 oz. The Apgar score at one minute was seven and at five minute it was nine. The fetus had no complications with delivery. Resuscitation done with mild tactile stimulation. There was no adverse event associated with this pregnancy therefore, treatment and reporter causality assessments were not applicable and the event administration to vaccine exposure during pregnancy was considered resolved. Additional information was received on 18-Nov-2009 and incorporated into the narrative: medical history, concomitant medications, concurrent condition. Also information received on reporter address and pregnancy EDD. Additional information was received on 28-Apr-2010 and incorporated into the narrative: pregnancy outcome, concomitant medication and neonatal information.
showed low titers for varicella; Patient received a dose of VARIVAX today via intamuscular route instead of subcutaneously; This spontaneous report has been received from a nurse referring to a 24 year old female patient. Information regarding the patient's medical history, drug reactions or allergies, and concurrent conditions was not provided. Concomitant therapies included sterile diluent.  On an unknown date, an unspecified antibody test was performed which showed low titers for varicella, therefore, on 28-AUG-2020, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX), intramuscularly instead of subcutaneously (incorrect route of product administration) (strength, indication, dose, frequency, anatomical location, lot # and expiration date were not provided) for prophylaxis.  On the same date, the patient also was vaccinated with an unspecified hepatitis a vaccine, inactivated (manufacturer unknown).
This spontaneous report as received from a medical assistant refers to a 11-year-old patient of unknown gender. No information about the patient's medical history and concurrent conditions were reported. On 08-FEB-2016, the patient was vaccinated with an improperly stored dose of GARDASIL lot # K008931, expiry date 04-MAR-2017, injected in the left arm (dose and route of administration were not reported). Concomitant therapy included meningococcal vaccine and Tdap. Administered doses were exposed to the following conditions: temperature of 33 Fahrenheit degrees for 15 hours and 15 minutes. There was no previous temperature excursion. It was not the case of a "data logger". No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all required correspondence was received.
This non-serious spontaneous case, was initially received from other health professional on 28-Sep-2017, concerning a 65-year-old, elderly female patient. The patient's medical history and concomitant medications were not reported. On 27-Sep-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, batch number: 185286, expiry date: 30-Apr-2017, route of administration, anatomical location: not reported). The patient received the expired dose of the product, which was considered as expired vaccine used. The reporter assessed the report as non-serious. Non-significant case correction received 28-Sep-2017: Batch number (185286) was added on the screen and updated expiry date. The narrative was amended accordingly.
Pt presents stating Tdap and PPD with clinic on 4/23/2010. Several hours after injection with following complaints - fatigue, quadricept muscle twitching, nausea, pain, headache, sleepiness all weekend, fever > 102 x 2 days but not today/Friday and Saturday trouble breathing until she later passed a "white living tissue, quarter size with blooded strips from right nostril, coughing with small amount of bloody tissue as well" loose bowel - severe sore throat, stiff neck but this better today. Watery, red eyes, swollen face. Pt states multiple heart condition and high blood pressure, MVP, hx stroke. Had surgery two weeks ago for rectal polyps. Pt denies any difficulty breathing today - 4/27/2010. No redness or swelling at injection sites today noted, referred to health care center for evaluation. Pt stated "I will not go".
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a consumer concerned a 45 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 24-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 24-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210955892.
Patient received vaccine at 12:15 pm on 9/13/06 at 13:05 patient found on floor having a seizure. Post-partum patient - delivered on 09/11/06 1929. History and Physical Report, Neuro Consultation and MRI of brain received. Two day post partum, generalized seizure. Scheduled for DC and 35-40 minutes prior to DC received Rubella vaccination. Found on the floor having a generalized seizure. She had dropped the baby but the baby is fine. Seizure lasted a couple of minutes and patient was confused for 20 minutes or so thereafter. That evening during consultation she felt fine but also tired, does not remember packing up her belongings and the next thing she remembers is waking up in her bed. No HX of seizures or syncope. No warning to this episode. Mother has epilepsy but seizures related to head injury in MVA. Neuro exam WNL. Lab results WNL, however, MRI of brain normal. EEG report pending. Impression: isolated generalized seizure. Circumstances suggest it might have been related to Rubella vaccination 35-40 minutes earlier. Doubt related to epidural anesthetic 2 days earlier since she had no sequelae from procedure. -DC Summary received: DC DX Term Pregnancy-Delivered.
Day of: Slight fatigue Next morning: Severe fatigue, severe joint pain, lightheadedness, severe headache, low grade fever (99) 2 days after: Slight fatigue, arm rash
two weeks after i was given the moderna vaccine i had very intense mental fog, fatigue, trouble sleeping, and joint pain. I have been taking prednisone for three weeks now and am starting to get better.
Approximately 15 minutes after vaccination, patient fainted while existing the exam room. She revived within a minute - Her B/P was normal, but her pulse was slow. She received O2 in office and was referred to a cardiologist.
Pt got a rash on her wrist, arm, chest and back, mostly on her right side. She got the vaccine in her left arm. The rash on her back: looks like chicken pox and it itches, but there is no pain. (rash not yet resolved).
Late at night I started experiencing rapid heartbeat and could not calm that by shifting my breathing. I am skilled in meditation breathing techniques and I could make no progress, so I decided to get in a hot bath. On the way I had difficulty walking -- dizzy -- and did take that bath that immediately helped my heart calm down an my breathing became normal. I got up and went directly to bed; when I woke up at 6 am I was sweating and had a temperature of 99.8.
Baby event home after shots, cried all night. Both feet became red & swollen until next morning.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Severe, Systemic: Nausea-Medium, Additional Details: patient presented on 10/11/21, 3 days following second covid shot given 10/8/21. He stated he felt awful all weekend, tired, achey, headache, nausea and today was the first day he felt well enough to get out of bed.  But also today he had new symptom of redness, swelling and itching in right deltoid, in the general area of injection and below.  Because he tated it was itching, I suggested bendadryl orally and to check in with his family dr
Pt rec'd vaccine in 11/07 - states had 2 stripes on flank that looked like shingles lasted 4-5 mos.
Patient did not have any adverse events, but was mistakenly given the Moderna vaccine when she was 16.
Patient was admitted for seizures on 5/5/2021 with plan to discharge to a post acute facility. He was negative for COVID-19 at admission. During discharge screening for facility, he was found to be COVID-19 positive. He was asymptomatic for COVID-19 and was discharged to facility on 5/22/2021. On 5/26/2021 he presented to the hospital again and was found to have a pulmonary embolism. He remained admitted until 6/6/2021.
Approximately 8 hours after my 2nd Moderna vaccination I began getting chilled and fatigued.  That lasted for about 12 hours.
Information has been received on 15-FEB-2019 regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 15-OCT-2013, the patient was administered the ZOSTAVAX vaccine (lot# and route not specified) by a healthcare provider. On an unspecified date, the patient was treated by a healthcare provider for shingles as a result of vaccination with ZOSTAVAX. The outcome was not provided. Additional information has been requested.
Severe joint point (required knee surgery) inability to participate in sports, eye problems, extreme nausea, anxiety, depression, decline in school performance. 60 Day Follow up states pt has not recovered. Pt continues to have joint problems that have left her unable to participate in sports or recreational (ie skiing) with her family. She has a multitude of problems (eyes, joint, etc) from this vaccine. COMMENTS: Why was this vaccine ever approved? Manufact. and FDA were aware of the risks and did not disclose them. This vaccine has had a severe negative impact on our entire family. What does the future hold for my children? Shame on everyone that was instrumental in approving this vaccine. I hope they (manufact) have family members (although I doubt it) that suffer as much as mine. This entire vaccine trial was a huge scam. Severe joint pain, fatigue, headaches, depression, nausea.
Pt was sitting in waiting area after receiving #1 injection of Pfizer Covid vaccine. He bagan to feel faint and presented to EMS Vitals taken BP 70/40 HR 40 O2 100% Blood sugar 96. Pt  diaphoretic. No difficulty breathing.
He suddenly suffered a severe stroke/blood clot in brain on January 19, 2021 which was 12 days after he received his first dose of the Moderna vaccine. He went via ambulance to hospital and was inpatient there at   Hospital for 2 nights.
Choreoathetosis-head, trunk, limbs improving with IV diphenhydramine and lorazepam prn.11/19 and 11/20/2009 MR for 11/6-11/9/2009.  DC DX Dyskinesias Patient with c/o's involuntary movements of limbs associated with paresthesias of feet bilaterally. Neuro exam absent reflexes, TX: IV Benadryl, PT and OT
Information has been received from a registered nurse concerning a 13 year old patient who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient may have developed a case of chicken pox. Unspecified medical attention was sought. THere was no product quality complaint involved. Additional information has been requested.
Patient presented with abdominal pain, found to have enteritis on CT. Infectious disease initially consulted as patient was incidentally COVID positive. She was started on a three day course of remdesivir with last dose 10/06/22. Patient's pain improved, she was started on bowel regimen. Diet was advanced, pain was controlled,  with return of bowel function, and patient ambulated. Patient was clinically cleared for discharge. She was instructed to follow a renal diet and follow up with labs on Monday for her hyperkalemia as well as with hepatology on Wednesday.
Nothing happened for a week, no symptoms. But a week later I developed chills, shoulder tension, muscle ache, fatigue, face irritation, brain fugue, tinnitus, I called my doctor, they recommended TYLENOL, symptom improved but they reoccurred; they recommended to go urgent care on 11/23 at 10:00AM to get advice, I was tested for COVID-19, Influenza A & B; RSV and all of tests were negative. I have an appointment with a provider to further investigate my health condition.
the sickest; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (the sickest) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 14-Apr-2021, the patient experienced ILLNESS (the sickest). At the time of the report, ILLNESS (the sickest) had not resolved.            Concomitant product use was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
This spontaneous report as received from a other health professional refers to a unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On 13-FEB-2015, unspecified number of patients were vaccinated with improperly stored ZOSTAVAX. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. No adverse events reported. This is one of several reports from the same source. Additional information has been requested.
Small pea-sized redness @ site of injection yesterday after school.  This morning pt c/o slight pain and site was itchy.  Mom noticed that redness had increased w/more itching and some pain when he came-home from school.  Mom gave BENADRYL to help.
numbness, tingling and muscle weakness in extremities and face. lasted for an hour or two.
Information has been received from a physician concerning a 12 month old female with no known drug allergies who on 5/16/97 was vaccinated with a dose of MMRII. There was no concomitant medication. On approx. 5/26/97, 10 days post vax, the pt developed a fever of 105F and a rash. The pt sought unspecified medical attention. Additional information has been requested.
Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Mild, Systemic: blurred/vision changes, tachycardia-Medium
This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient's son/daughter. The age at vaccination was not reported. The reporter reported that his/her mom had the shot and has had shingles twice now. The reporter stated you just did not know. The follow could not be possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Swelling, redness, itching at site of injection - (2) 25 mg BENADRYL, ice pack.
She said within hour inside of her arm (opposite side from injection in deltoid) became swollen, red, painful, and warm to touch from slightly above elbow to mid forearm. Progressively improved.
Swollen lymph nodes along left side of jaw, cheek, and underneath the ear. Pain along left side as result of swollen lymph nodes. Headache.